These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species. Lundberg AP; Francis JM; Pajak M; Parkinson EI; Wycislo KL; Rosol TJ; Brown ME; London CA; Dirikolu L; Hergenrother PJ; Fan TM Invest New Drugs; 2017 Apr; 35(2):134-144. PubMed ID: 27975234 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation. Xu S; Yao H; Pei L; Hu M; Li D; Qiu Y; Wang G; Wu L; Yao H; Zhu Z; Xu J Eur J Med Chem; 2017 May; 132():310-321. PubMed ID: 28395199 [TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of NADPH quinine oxidoreductase 1 overexpression in head and neck squamous cell carcinoma]. Yang Y; Jin T; Liu S; Chen L; Lin L; Han H; Li L; Lin Z Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):463-7. PubMed ID: 25327796 [TBL] [Abstract][Full Text] [Related]
11. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Winski SL; Hargreaves RH; Butler J; Ross D Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer. Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614 [TBL] [Abstract][Full Text] [Related]
13. Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma. Lundberg AP; Tran Hoang C; Billhymer A; Selting KA Vet Comp Oncol; 2022 Dec; 20(4):788-796. PubMed ID: 35561080 [TBL] [Abstract][Full Text] [Related]
14. Natural Small Molecules as Stabilizers and Activators of Cancer-Associated NQO1 Polymorphisms. Pey AL; Megarity CF; Medina-Carmona E; Timson DJ Curr Drug Targets; 2016; 17(13):1506-14. PubMed ID: 26721407 [TBL] [Abstract][Full Text] [Related]
15. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo. Zhang X; Su Y; Zhang M; Sun Z Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346 [TBL] [Abstract][Full Text] [Related]
17. A small molecule chaperone rescues the stability and activity of a cancer-associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro. Strandback E; Lienhart WD; Hromic-Jahjefendic A; Bourgeois B; Högler A; Waltenstorfer D; Winkler A; Zangger K; Madl T; Gruber K; Macheroux P FEBS Lett; 2020 Feb; 594(3):424-438. PubMed ID: 31605637 [TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of toceranib phosphate (Palladia) in cats with oral squamous cell carcinoma. Wiles V; Hohenhaus A; Lamb K; Zaidi B; Camps-Palau M; Leibman N J Feline Med Surg; 2017 Feb; 19(2):185-193. PubMed ID: 26755491 [TBL] [Abstract][Full Text] [Related]
19. A naturally occurring feline model of head and neck squamous cell carcinoma. Wypij JM Patholog Res Int; 2013; 2013():502197. PubMed ID: 23970998 [TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism. Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]